Skip to main content

Closed

OCUL: Ocular Therapeutix, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+9.0% / yr

Operating margin-575.4%

ROIC-43.5%

Financially safe

Stretched

Debt / equity0.14×

Interest coverage-25.8×

Current ratio14.81×

Ocular Therapeutix, Inc.

OCULNASDAQ Global Market·USD·Closed

Ocular Therapeutix, Inc.

OCULNASDAQ·USD·Closed

$8.17

−3.54%

$8.17

−$0.30 (3.54%)

52W Range

19thpctl

Volume

0.79×avg

Mkt Cap

1.79BUSD

P/E

-5.6TTM

Div Yield

–ann

52W Range

19thpctl

Volume

0.79×avg

Market Cap

1.79BUSD

P/E Ratio

-5.6TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings